CN110115645A - Multi path artificial nerve trachea and preparation method thereof - Google Patents

Multi path artificial nerve trachea and preparation method thereof Download PDF

Info

Publication number
CN110115645A
CN110115645A CN201910312750.5A CN201910312750A CN110115645A CN 110115645 A CN110115645 A CN 110115645A CN 201910312750 A CN201910312750 A CN 201910312750A CN 110115645 A CN110115645 A CN 110115645A
Authority
CN
China
Prior art keywords
nerve
nerve trachea
tube body
trachea tube
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910312750.5A
Other languages
Chinese (zh)
Inventor
艾合买提江·玉素甫
亚穆罕默德·阿力克
阿里木江·阿不来提
任鹏
马创
阿不来提·阿不拉
夏依买尔旦·买买提
买买艾力·玉山
程二林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
First Affiliated Hospital of Xinjiang Medical University
Original Assignee
First Affiliated Hospital of Xinjiang Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by First Affiliated Hospital of Xinjiang Medical University filed Critical First Affiliated Hospital of Xinjiang Medical University
Priority to CN201910312750.5A priority Critical patent/CN110115645A/en
Publication of CN110115645A publication Critical patent/CN110115645A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/222Gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/32Materials or treatment for tissue regeneration for nerve reconstruction

Abstract

The present invention relates to multi path artificial nerve trachea and preparation method thereof, the bridge joint that can be used for customizing repairs that neurologic defect position is remote, proximal end.It is disclosed by the invention to customize the multi path artificial nerve trachea for imitating the natural anatomical structure of nerve, it mainly include to imitate the natural multichannel bracket (nerve trachea tube body) of anatomical structure of nerve and the biofilm structure (nerve trachea tube wall) of its outer layer covers.What tube body multi-channel structure can customize organizes the formation of better matching relationship with the nerve tract of different zones and size in nerve to be repaired, by guiding the specific nerve tract tissue in neurologic defect position proximal end to reach distal end in different customization channel designs, realize that reduce nerve tract dissipates growth during the growth process, be interweaved phenomenon, advantageously reduces the mismatch rate of proximal end new life nerve tract tissue and distal end target area.

Description

Multi path artificial nerve trachea and preparation method thereof
Technical field
The present invention relates to nerve trachea fields, are a kind of bionical multichannels of customization for imitating the natural anatomical structure of nerve Artificial nerve catheter designs preparation method.
Background technique
Peripheral nerve injury is a kind of common clinical problem, it is often caused by serious damage, so as to cause nerve Defect.For being more than the defect of 4mm, simple direct sewing method cannot be taken, and need to defect proximally and distally between mention It is bridged for graft.Nerve autograft be currently repair neurologic defect " goldstandard ", but its frequently result in donor site damage and Functional rehabilitation is imperfect.
Nerve trachea has been developed that into a kind of method that neurologic defect is repaired in substitution autotransplantation, and structure only limits at present In simple single channel or with the multi-channel structure of regular matrix.However, the natural anatomical structure of nerve tract is not this letter Single single channel lumen or regular matrix structure, the size and number of nerve tract have obvious between different plant species, Different Individual Difference, its arrangement mode is all not all the same in its different cross section for even same nerve.
Therefore, nerve trachea structure at this stage is only limitted to the multichannel nerve conduit of single channel or regular matrix, cannot Arrangement and distribution of the good analog neuron beam in nerve can not really restore the dry middle multiple groups nerve tract of original nerve three Distribution and rule out of shape on dimension space, above-mentioned nerve trachea structure are not applied to the best of recovery peripheral nerve defection Selection.
Summary of the invention
The object of the present invention is to provide a kind of multi path artificial nerve trachea, customizes and imitates the natural anatomical structure of nerve, It is internal with anatomy multiple groups channel design similar with target nerve to be repaired, being capable of axially directed nerve tract arrival Distal end dominates area, and neurologic defect position is matched good isolated internal channel and be bridged with a plurality of.
Another object of the present invention is to provide a kind of methods for preparing above-mentioned multi path artificial nerve trachea.
Multi path artificial nerve trachea of the present invention mainly includes nerve trachea tube body, is equipped in nerve trachea tube body multiple Imitate the channel of the natural anatomical structure of nerve, the outer layer covers nerve trachea tube wall of nerve trachea tube body, nerve trachea tube wall For biofilm structure, it is used to analog neuron adventitial tissue.
Nerve trachea tube body and nerve trachea tube wall, are formed by one or more Material claddings, and have be interconnected Porous structure, conducive to carrying out between nerve trachea tubular body and outside, nutriment is exchanged and waste is discharged.It is understood that It is that nerve trachea tube body is equipped with porous structure, porous structure is again provided on nerve trachea tube wall, due to nerve trachea pipe Wall wraps up nerve trachea tube body, then the two is interconnected by porous structure.
Number of channels be it is multiple, each access needle to different parts target nerve beam design different contours profiles etc. ginseng Number, multichannel lumen diameter is usually 100-2000 μm.
The multi-channel structure being arranged in nerve trachea tube body is with the anatomy of nerve tract each in target nerve to be repaired Parameter is foundation, the single nerve tract of single channel priority match in multi-channel structure, when single channel need to match more nerve tracts When, the multiple groups nerve tract of closely located or target organ structure, function identical (or similar) is preferentially integrated into a channel.
In multi path artificial nerve trachea implantation process, the lumen in multiple channels in nerve trachea tube body can with it is to be repaired Multiple neurologic defect both ends nerve tract organizes the formation of matched well relationship.
Further, multi-channel structure, which is provided, forms beam group with the consistent guidance in original nerve beam direction out of shape, help proximal end Nerve fiber docked with the corresponding target area in distal end, passing through, which reduces mismatch rate, promotes neurological functional recovery.
The both ends of nerve trachea tube wall are longer than the both ends of nerve trachea tube body, and length is longer than tube body both ends 1-3mm, use It is acted in providing with perilemma epineurium bridge joint, nerve trachea pipe thickness is 100-400 μm.
Nerve trachea tube wall provides protection for repair process, specifically:
When axial drawing of the nerve fiber by some strength, nerve trachea tube wall passes through pulls and extends Dispersion drawing stress, when axial stress is more than that tube wall extends the limit, fracture occurs for tube wall to avoid nerve fiber by excess load Drawing and be further damaged.
Outer wall and internal layer tube body have synergistic mechanism during neural restoration, and tube wall and tube body are presented fast, slow two Kind degradation rate.The premature degradation of tube wall in vivo can raise regeneration chamber periphery and generate (the cleaning of more macrophages Effect), clean regenerative environ-ment is provided for newborn nerve fiber.The slow degradation process of tube body can provide sufficient space size and The nerve regneration channel of support strength is the powerful guarantee of the intracavitary good blood fortune circulation of tube channel, discharge nerve can be assisted disconnected The cell and metabolic waste of surface damage.
The multi path artificial nerve trachea of customization can drive nerve tract to be formed in the multichannel of customization and original mind Through similar multiple channel (beam group) structures of trunk, the long axis direction and nerve tract in each channel are out of shape consistent in neural trunk, Newborn nerve fiber in channel, meets the out of shape and regularity of distribution of the nerve tract in nerve naturally, and directional guide proximal end is newborn The corresponding target area in the distal end nerve tract Zhi Peizhi, to improve neural restoration accuracy.By by the above-mentioned nerve regneration channel with Matched to neural broken ends of fractured bone section nerve tract tissue, can reduce newborn nerve tract be interweaved in nerve graft, nothing The case where sequence is grown, advantageously reduces the mismatch rate of proximal end new life nerve tract tissue and distal end target area.
The present invention compared with the existing technology the advantages of be nerve trachea tube body multi-channel structure have and the neural broken ends of fractured bone cut The similar engineering anatomic morphological of the nerve tract in face.Channel and nerve tract can form preferable matching relationship, thus by one group or Multiple groups structure, the similar nerve tract of function and source are limited in specific nerve regneration channel, pass through nerve trachea tube wall The growth of the unordered divergence expression of physical centralization effect limitation nerve, improves the neural axon quantity in unit area, drives new life Nerve in channel formed beam group.Further, nerve tract is out of shape in the multichannel lumen long axis and original nerve tissue of conduit Unanimously, the neural directional guide of above-mentioned Shu Zuhua to the corresponding target area in distal end can be docked.Its advantages are by reducing mind Neurological functional recovery effect is improved through mispairing incidence.
Detailed description of the invention
In order to more clearly explain the embodiment of the invention or the technical proposal in the existing technology, below will to embodiment or Attached drawing needed to be used in the description of the prior art is briefly described, it should be apparent that, the accompanying drawings in the following description is only The embodiment of the present invention for those of ordinary skill in the art without creative efforts, can be with Other attached drawings are obtained according to the attached drawing of offer.
Fig. 1 is to intend bionical new zealand white rabbit sciatic nerve cross section tissue slice map.
Fig. 2 is the present invention 4 channel artificial nerve catheter lumen section views of design, the nerve in channel and target nerve The matching relationship of beam.
Fig. 3 is to prepare CANC process using die methods, is illustrated: 1. duct forming molds, 2. conduits are socketed mold, 3. thimble, 4.15% (w/v) gelatin solution, 5. tube bodies (multichannel bracket), 6. tube walls (PLGA biomembrane), 7.CANC conduit.
Fig. 4 is CANC structure observation under scanning electron microscope, observes catheter outer PLGA under A. scanning electron microscope Biomembrane (140 times of amplification), rectangular box enlarged drawing (corresponding B, amplify 500 times) display PLGA fibre diameter and pore structure, C is multi-channel structure (amplification 20 times) of the observation using 4 passage catheters as representative, rectangular box amplification under scanning electron microscope Figure (corresponding D, amplify 200 times) display gelatin pore structure.
Fig. 5 is Fluorescence Retrograde Tracing detection, A. new zealand white rabbit sciatic nerve trunk (S) and its nervus tibialis branch (T), nervus peroneus communis branch (P), B. Fluorescence Retrograde Tracing detection ideograph.(a, b) is that tracer drives in the wrong direction through nerve tract respectively The simulation drawing out of shape in single channel conduit (1-CANC) or multichannel (4-CANC), quilt C.1-CANC and in 4-CANC reparation group The neuronal quantity situation of NY, FB, FB-NY label, FB-NY is by Fluorescence Retrograde mark D.1-CANC and in 4-CANC reparation group Remember the percentage of neuron.
Fig. 6 is the neural tissue slice result and analysis repaired using 1-CANC and 4-CANC, A. Toluidine blue staining method And two kinds of conduits of 1-CANC, 4-CANC are observed under transmission electron microscope and repair nerve slice as a result, B. analysis more above-mentioned two Difference of the nerve trachea of kind in terms of regenerated nervous fibers quantity, density, diameter and fiber myelin wall thickness.
Fig. 7 is each conduit cavity internal diameter parameter, and data show that all conduit cavity cross-sectional areas are almost the same in table, Match index (MI) shows that the matching degree of nerve trachea channel and beam, 4-CANC and target nerve matching are higher than 1-CANC.
Specific embodiment
Embodiment 1
Intend bionical new zealand white rabbit sciatic nerve tissues slice according to shown in FIG. 1, it is more that customization designs one kind Channel artificial nerve catheter, the multi path artificial nerve trachea include nerve trachea tube body, and it is logical to be equipped with 4 in nerve trachea tube body Road, then the multi path artificial nerve trachea is 4 channel nerve tracheas (4-CANC), is designed using computer aided design software Conduit cross section is as shown in the figure for being located at right side in Fig. 2.
Nerve trachea tube body is ellipsoidal structure, and nerve trachea tube length 10mm, the long axis of nerve trachea tube body is 4mm, the short axle of nerve trachea tube body are 2.5mm.
It is equipped with 4 channels in nerve trachea tube body, is respectively defined as 1# lumen described in figure channel, 2# lumen channel, 3# Lumen channel, 4# lumen channel
1# lumen channel diameter is 1.2mm, and 2# lumen channel diameter is 0.7mm, and 3# lumen channel diameter is 0.7mm, 4# Lumen channel diameter is 0.6mm.
Lumen perimeter 10.05mm, lumen gross area 2.18mm2, match index (MI) 84.4% (table 1).
It compares with 4 channel nerve tracheas (4-CANC), the figure in Fig. 2 positioned at left side provides a kind of 1 channel mind Through conduit (1-CANC), 1# lumen channel diameter is 1.7mm, match index (MI) 75.5% (table 1).
Multi path artificial nerve trachea (CANC) with above structure is prepared by means of mold shown in Fig. 3, Above-mentioned data file importing printer is prepared into mold, specific as follows:
One, prepared by nerve trachea tube body (multichannel bracket)
1. gelatin particle is dissolved in deionized water, configuration concentration is 15% (w/v) gelatin solution.
2. pouring gelatin solution to socket mold (2) and correspondingly configured mold (1), required successively according to channel diameter It is inserted into the thimble (3) of respective diameters, freezing solid is carried out in -80 DEG C of refrigerators.
As shown in figure 3, socket mold (2) has both ends open, it is respectively embedded into molding die (1) in both ends open, up and down There is the cavity for accommodating gelatin solution between two molding dies (1), be then inserted into respectively by two molding dies (1) more The purpose of a thimble (3), insertion thimble (3) is to produce the intracorporal channel of nerve trachea pipe, carry out in -80 DEG C of refrigerators Freeze solid.
3. rapidly removal both mold ends fixation after, remove thimble (3), release gelatin conduit, be placed in be pre-chilled it is cold It is lyophilized 48 hours in lyophilizer.
It after cryofixation, removes thimble (3), the molding die (1) at removal socket mold (2) both ends is then solid by freezing The gelatin conduit of shape is released, and is placed in the freeze drier being pre-chilled and is lyophilized 48 hours.
4. freeze-drying forming processing: the parameter of setting being lyophilized in freeze drier are as follows: -30 DEG C, 0.05mPa continuous freeze-drying 12 Hour, it is warming up to 0 DEG C of holding 6h under vacuum state, is warming up to 22 DEG C of holding 30-60min, vacuum is released and rises to room temperature, obtain Uncrosslinked nerve trachea tube body.
5. cross-linking process: be placed in N- (3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC, it is molten Spend 0.12mol/L) and N-hydroxysuccinimide (NHS, solubility 0.06mol/L) mixed solution in, be crosslinked at 4 DEG C Reaction 12 hours obtains multichannel nerve conduit tube body (5).
Two, prepared by nerve trachea tube wall (PLGA biomembrane):
1. PLGA particle (LA:GA=75:25, molecular weight 100000) is dissolved in dichloromethane solution, being made into concentration is The PLGA solution of 10% (w/v).
2. PLGA solution is transferred in the 10ml glass syringe of electrostatic spinning machine and is connected with Teflon pipe.
3. setting distance 15cm between the spinning syringe needle and receiver board of electrostatic spinning agent, the horizontal movement velocity of receiver board For 0.00147mm/s, the injection rate for adjusting syringe is 3mL/h, and adjusting electrostatic spinning machine output voltage is 13-15kV, even Continuous spinning 1h, obtains PLGA biomembrane (6), as nerve trachea tube wall.
The mode of nerve trachea tube body and the synthesis of nerve trachea tube wall are as follows: the PLGA biomembrane (6) of acquisition is placed in 40 DEG C Vacuum drying oven in dry after with a small amount of gelatin solution the PLGA biomembrane (6) of acquisition is fixed on nerve trachea tube body (5) Surface obtains CANC (7) and observes (Fig. 3) under a scanning electron microscope.
Above-mentioned CANC (7) are subjected to animal surgery and repairing effect assessment, specifically, the CANC (7) of acquisition is passed through Co60New zealand white rabbit Sciatic (10mm) model is implanted into after illumination-based disinfection sterilizing.It performs the operation under special microscope in 8X Remote, the Proximal beam arrangement architecture (Fig. 2) according to neurologic defect, after catheter channel is matched with nerve tract, by PLGA biomembrane (6) neurologic defect both ends perilemma epineurium structure is fixed on micro- dedicated suture.Postoperative conventinal breeding is adopted in given time point With Fluorescence Retrograde Evaluation of detection methods nerve regneration accuracy (Fig. 5), nerve regneration quality and quantity then uses micro- sem observation Neurohistology dicing method assesses (Fig. 6).
Comparative example 1
1 channel nerve trachea of design is customized according to new zealand white rabbit sciatic nerve tissues slice result (Fig. 1) (1-CANC) designs conduit cross section (Fig. 2) using computer aided design software, and conduit is ellipsoidal structure, catheter length 10mm, conduit long axis are 4mm, and short axle 2.5mm, 1# lumen channel diameter is 1.7mm, lumen perimeter 5.34mm, the lumen gross area 2.27mm2, match index (MI) 77.1%.Remaining step is the same as embodiment 1.
Experimental result is shown:
Regenerate accuracy evaluation: 4-CANC and 1-CANC have same population fluorescent marker neuron (FB-, NY-, FB-NY the neuron (FB-NY) of mispairing), and in 4-CANC occurs relative to 1-CANC negligible amounts (Fig. 5).Regenerating nerve is fine Dimension amount, quality evaluation: 4-CANC and 1-CANC is all the same in terms of the sum and density of newborn medullated fibers, and In terms of medullated fibers diameter and its myelin wall thickness, 4-CANC is better than 1-CANC (Fig. 6).
It is grown in conclusion embodiment limits nerve tract divergence expression in lumen relative to comparative example, reduces nerve Mismatch rate, and show the advantage that medullated fibers is reached maturity that can promote.
The above embodiments are merely illustrative of the technical solutions of the present invention, rather than its limitations;Although with reference to the foregoing embodiments Invention is explained in detail, those skilled in the art should understand that: it still can be to aforementioned each implementation Technical solution documented by example is modified or equivalent replacement of some of the technical features;And these modification or Replacement, the spirit and scope for technical solution of various embodiments of the present invention that it does not separate the essence of the corresponding technical solution.

Claims (9)

1. a kind of multi path artificial nerve trachea, which is characterized in that including nerve trachea tube body, outside the nerve trachea tube body Layer package nerve trachea tube wall;Multiple channels are equipped in nerve trachea tube body;The nerve trachea tube body and the nerve trachea Tube wall is formed by one or more Material claddings, and has interconnected porous structure.
2. multi path artificial nerve trachea according to claim 1, which is characterized in that nerve trachea tube wall both ends Length is longer than the nerve trachea tube body.
3. a kind of preparation method of multi path artificial nerve trachea, which is characterized in that multi path artificial nerve trachea includes nerve Catheter tube, the outer layer covers nerve trachea tube wall of the nerve trachea tube body;Nerve trachea tube body the preparation method comprises the following steps: step One, gelatin particle is dissolved in deionized water, the gelatin solution that configuration concentration is 15%;Step 2 pours gelatin solution to mould Tool, freezing solid is carried out in -80 DEG C of refrigerators, obtains gelatin conduit;Gelatin conduit is lyophilized and shapes, do not handed over by step 3 The nerve trachea tube body of connection;Uncrosslinked nerve trachea tube body and mixed solution are carried out cross-linking reaction, obtain nerve by step 4 Catheter tube.
4. the preparation method of multi path artificial nerve trachea according to claim 3, which is characterized in that mold includes both ends The socket mold of opening, both ends open are respectively embedded into molding die, have between upper and lower two molding dies and accommodate gelatin solution Cavity.
5. the preparation method of multi path artificial nerve trachea according to claim 4, which is characterized in that in step 2, When gelatin solution is poured to mold, multiple thimbles are inserted by two molding dies respectively, are carried out in -80 DEG C of refrigerators cold Freeze solid, obtains gelatin conduit.
6. the preparation method of multi path artificial nerve trachea according to claim 5, which is characterized in that in step 3, Gelatin conduit is placed in the freeze drier being pre-chilled and is lyophilized 48 hours, obtains uncrosslinked nerve trachea tube body.
7. the preparation method of multi path artificial nerve trachea according to claim 6, which is characterized in that, will in step 4 Uncrosslinked nerve trachea tube body is placed in N- (3-dimethylaminopropyl)-N'-ethylcarbodiimide and N- In hydroxysuccinimide mixed solution, cross-linking reaction 12 hours at 4 DEG C obtain nerve trachea tube body.
8. the preparation method of multi path artificial nerve trachea according to claim 3, which is characterized in that nerve trachea tube wall The preparation method comprises the following steps: step 5, by PLGA grain dissolution in dichloromethane solution, being made into concentration is 10%PLGA solution;Step 6, PLGA solution is transferred in the 10ml glass syringe of electrostatic spinning machine and is connected with Teflon pipe, continuous spinning 1h is obtained Nerve trachea tube wall.
9. the preparation method of multi path artificial nerve trachea according to claim 8, which is characterized in that nerve trachea tube body With the mode of nerve trachea tube wall synthesis are as follows: the nerve trachea tube wall of acquisition is placed in 40 DEG C of vacuum drying oven after drying, is used The nerve trachea tube wall of acquisition is fixed on nerve trachea tube surfaces by a small amount of gelatin solution.
CN201910312750.5A 2019-04-18 2019-04-18 Multi path artificial nerve trachea and preparation method thereof Pending CN110115645A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910312750.5A CN110115645A (en) 2019-04-18 2019-04-18 Multi path artificial nerve trachea and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910312750.5A CN110115645A (en) 2019-04-18 2019-04-18 Multi path artificial nerve trachea and preparation method thereof

Publications (1)

Publication Number Publication Date
CN110115645A true CN110115645A (en) 2019-08-13

Family

ID=67521228

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910312750.5A Pending CN110115645A (en) 2019-04-18 2019-04-18 Multi path artificial nerve trachea and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110115645A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110584829A (en) * 2019-09-17 2019-12-20 深圳兰度生物材料有限公司 Nerve repair catheter
CN110975008A (en) * 2019-12-18 2020-04-10 武汉理工大学 Preparation method of nerve repair drug delivery system with electrical stimulation and angiogenesis promotion effects

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002047557A1 (en) * 2000-12-15 2002-06-20 The University Of Nottingham Nerve regeneration
CN1593354A (en) * 2004-06-25 2005-03-16 清华大学 Nerve tissue engineering tube type bracket and method for making same
CN2830409Y (en) * 2004-05-18 2006-10-25 中山大学附属第一医院 Tissue engineering ambient nerve graft
US20070010831A1 (en) * 2002-08-01 2007-01-11 Romero-Ortega Mario I Biomimetic biosynthetic nerve implant
CN101084025A (en) * 2004-09-14 2007-12-05 新加坡科技研究局 Porous biomaterial-filler composite and a method for making the same
CN101312756A (en) * 2005-11-17 2008-11-26 格利达股份公司 Nerve guide
US20120150205A1 (en) * 2009-08-12 2012-06-14 Snu R&Db Foundation Silk nanofiber nerve conduit and method for producing thereof
US20130331869A1 (en) * 2009-10-16 2013-12-12 M. Brett Runge Conductive polymeric composites of polycaprolactone fumarate and polypyrrole for nerve regeneration
CN103648536A (en) * 2011-04-05 2014-03-19 弗赖堡大学医院 Biocompatible and biodegradable gradient layer system for regenerative medicine and for tissue support
CN104382672A (en) * 2014-11-14 2015-03-04 东华大学 Double-layer multichannel nerve conduit and preparation method thereof
CN108977405A (en) * 2018-08-09 2018-12-11 西南大学 A kind of instant 3D cell growth bracket and preparation method thereof
CN109172036A (en) * 2018-06-22 2019-01-11 中山大学附属第医院 A kind of multichannel peripheral nerve conduit and preparation method thereof

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002047557A1 (en) * 2000-12-15 2002-06-20 The University Of Nottingham Nerve regeneration
US20070010831A1 (en) * 2002-08-01 2007-01-11 Romero-Ortega Mario I Biomimetic biosynthetic nerve implant
CN2830409Y (en) * 2004-05-18 2006-10-25 中山大学附属第一医院 Tissue engineering ambient nerve graft
CN1593354A (en) * 2004-06-25 2005-03-16 清华大学 Nerve tissue engineering tube type bracket and method for making same
CN101084025A (en) * 2004-09-14 2007-12-05 新加坡科技研究局 Porous biomaterial-filler composite and a method for making the same
CN101312756A (en) * 2005-11-17 2008-11-26 格利达股份公司 Nerve guide
US20120150205A1 (en) * 2009-08-12 2012-06-14 Snu R&Db Foundation Silk nanofiber nerve conduit and method for producing thereof
US20130331869A1 (en) * 2009-10-16 2013-12-12 M. Brett Runge Conductive polymeric composites of polycaprolactone fumarate and polypyrrole for nerve regeneration
CN103648536A (en) * 2011-04-05 2014-03-19 弗赖堡大学医院 Biocompatible and biodegradable gradient layer system for regenerative medicine and for tissue support
CN104382672A (en) * 2014-11-14 2015-03-04 东华大学 Double-layer multichannel nerve conduit and preparation method thereof
CN109172036A (en) * 2018-06-22 2019-01-11 中山大学附属第医院 A kind of multichannel peripheral nerve conduit and preparation method thereof
CN108977405A (en) * 2018-08-09 2018-12-11 西南大学 A kind of instant 3D cell growth bracket and preparation method thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110584829A (en) * 2019-09-17 2019-12-20 深圳兰度生物材料有限公司 Nerve repair catheter
CN110975008A (en) * 2019-12-18 2020-04-10 武汉理工大学 Preparation method of nerve repair drug delivery system with electrical stimulation and angiogenesis promotion effects

Similar Documents

Publication Publication Date Title
Petcu et al. 3D printing strategies for peripheral nerve regeneration
Bozkurt et al. The role of microstructured and interconnected pore channels in a collagen-based nerve guide on axonal regeneration in peripheral nerves
Wong et al. Macro-architectures in spinal cord scaffold implants influence regeneration
Pateman et al. Nerve guides manufactured from photocurable polymers to aid peripheral nerve repair
Hudson et al. Engineering strategies for peripheral nerve repair
EP1076533B1 (en) Guided development and support of hydrogel-cell compositions
EP1242129B1 (en) Biological joint construct
Park et al. Functional recovery guided by an electrospun silk fibroin conduit after sciatic nerve injury in rats
JP4746046B2 (en) Methods and devices for improved growth of peripheral nerves and neural tissue
CN101355974B (en) Bio-artificial materials with tuneable properties
CN105473103B (en) A kind of artificial trachea prosthese and/or pronunciation prosthetic material and its manufacturing method
Cui et al. Functional collagen conduits combined with human mesenchymal stem cells promote regeneration after sciatic nerve transection in dogs
CN108026508A (en) The Multi-level Organization Structure of continuous biometric print
Yen et al. Novel electrospun poly (ε-caprolactone)/type I collagen nanofiber conduits for repair of peripheral nerve injury
Meder et al. Nerve-specific extracellular matrix hydrogel promotes functional regeneration following nerve gap injury
CN110115645A (en) Multi path artificial nerve trachea and preparation method thereof
US20160250385A1 (en) Neuronal replacement and reestablishment of axonal connections
CN110475528A (en) Bionical implantation material
CN101072593B (en) Methods and apparatus for enhanced growth of peripheral nerves and nervous tissue
US9993581B2 (en) Engineered neural tissue
CN105457103A (en) 3D-printed peripheral nerve conduit and preparing method thereof
Sullivan et al. Implantation of engineered axon tracts to bridge spinal cord injury beyond the glial scar in rats
Nikkhah et al. Microtransplantation of nigral dopamine neurons: a step-by-step recipe
US20080003205A1 (en) Tympanic Membrane Repair Constructs
CN106563171A (en) Nerve scaffold/conduit material and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190813